Omega Therapeutics, Inc.
OMGADelisted Mar 20, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850838
Omega Therapeutics, Inc. was delisted on Mar 20, 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Omega Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 47 | 44 | −3 |
| Shares | 42.5M | 42.6M | +121.1K (+0.3%) |
| Value | $161.4M | $230.9M | +$69.5M (+43.0%) |
New holders (4)
Institutions that held Omega Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 3,604 | $20.0K | 0.00% |
| Cutler Group LP | 700 | $3.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 448 | $2.00K | 0.00% |
| State of Wyoming | 35 | $0 | 0.00% |
Sold out (7)
Institutions that held Omega Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Renaissance Technologies LLC | 95,663 | $364.0K |
| Rafferty Asset Management, LLC | 31,706 | $120.0K |
| D. E. Shaw & Co., Inc. | 15,327 | $58.0K |
| Schonfeld Strategic Advisors LLC | 13,600 | $51.0K |
| New York State Common Retirement Fund | 230 | $1.00K |
| TD Waterhouse Canada Inc. | 240 | $866 |
| Credit Suisse AG | 12 | $0 |